We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUP
12351
DELISTED
Superior Industries International
SUP
$81K ﹤0.01%
17,413
-8,192
-32% -$35.8K
PSTX
12352
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$81K ﹤0.01%
18,137
-6,877
-27% -$31K
MDH.WS
12353
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
$81K ﹤0.01%
515,518
+19,662
+4% +$5.07K
FRMM
12354
Forum Markets
FRMM
$83.2M
$80K ﹤0.01%
8
-16
-67% -$184K
BCDA icon
12355
PUT
BioCardia
BCDA
$14.4M
$80K ﹤0.01%
2,573
-67
-3% -$1.99K
CTRM icon
12356
Castor Maritime
CTRM
$20.2M
$80K ﹤0.01%
4,354
-61,369
-93% -$948K
TH icon
12357
CALL
Target Hospitality
TH
$1.6B
$80K ﹤0.01%
+13,400
New +$52.2K
TROO icon
12358
PUT
TROOPS Inc
TROO
$244M
$80K ﹤0.01%
18,600
-12,400
-40% -$54.1K
RNLX
12359
PUT
DELISTED
Renalytix plc American Depositary Shares
RNLX
$80K ﹤0.01%
11,600
+800
+7% +$8.47K
SMED
12360
CALL
DELISTED
Sharps Compliance Corp
SMED
$80K ﹤0.01%
+13,500
New +$84.8K
DOYU
12361
PUT
DouYu International Holdings
DOYU
$134M
$79K ﹤0.01%
3,800
-3,330
-47% -$73.4K
PMCB icon
12362
CALL
PharmaCyte Biotech
PMCB
$5.86M
$79K ﹤0.01%
34,500
+21,800
+172% +$48.4K
VNRX icon
12363
VolitionRx Ltd
VNRX
$9.24M
$79K ﹤0.01%
1,307
+760
+139% +$43.1K
RMGCW
12364
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$79K ﹤0.01%
180,000
NETI
12365
CALL
DELISTED
Eneti Inc.
NETI
$79K ﹤0.01%
+12,500
New +$84.8K
FTPAW
12366
DELISTED
FTAC Parnassus Acquisition Corp. Warrant
FTPAW
$79K ﹤0.01%
209,525
-1,765
-0.8% -$1.01K
HIIIW
12367
DELISTED
Hudson Executive Investment Corp. III Warrant
HIIIW
$79K ﹤0.01%
200,466
-129,592
-39% -$64.8K
ABOS icon
12368
PUT
Acumen Pharmaceuticals
ABOS
$176M
$78K ﹤0.01%
+20,000
New +$109K
AFMD
12369
CALL
DELISTED
Affimed
AFMD
$78K ﹤0.01%
+1,790
New +$77.8K
BBAI.WS icon
12370
BigBear.ai Holdings Warrant
BBAI.WS
$44.8M
$78K ﹤0.01%
88,679
-114,993
-56% -$95.3K
MBAI
12371
Check-Cap
MBAI
$10.1M
$78K ﹤0.01%
9,979
+8,969
+888% +$94K
NL icon
12372
NLI Holdings
NL
$308M
$78K ﹤0.01%
+10,782
New +$72.5K
QUAD icon
12373
PUT
Quad
QUAD
$507M
$78K ﹤0.01%
11,300
-1,300
-10% -$6.81K
SHCR
12374
CALL
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$78K ﹤0.01%
31,600
-58,700
-65% -$193K
GETR.WS
12375
DELISTED
Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
GETR.WS
$78K ﹤0.01%
141,074
-12,237
-8% -$6.84K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.